References
1. Barile L, Vassalli G (2017) Exosomes: therapy
delivery tools and biomarkers of diseases. Pharmacol Ther 174:63–78. https://doi.org/10.
1016/j.pharmthera.2017.02.020
2. Choi
D,
Lee
TH,
Spinelli
C,
Chennakrishnaiah S, D’Asti E, Rak J (2017)
Extracellular vesicle communication pathways
as regulatory targets of oncogenic transformation. Semin Cell Dev Biol 67:11–22. https://
doi.org/10.1016/j.semcdb.2017.01.003
3. Chistiakov DA, Orekhov AN, Bobryshev YV
(2016) Cardiac extracellular vesicles in normal
and infarcted heart. Int J Mol Sci 17(1):63.
https://doi.org/10.3390/ijms17010063
4. Han L, Lam EW, Sun Y (2019) Extracellular
vesicles in the tumor microenvironment: old
stories, but new tales. Mol Cancer 18(1):59.
https://doi.org/10.1186/s12943-019-0980-8
5. D’Anca M, Fenoglio C, Serpente M, Arosio B,
Cesari M, Scarpini EA, Galimberti D (2019)
Exosome determinants of physiological aging
and age-related neurodegenerative diseases.
Front Aging Neurosci 11:232. https://doi.
org/10.3389/fnagi.2019.00232
6. Yuan O, Lin C, Wagner J, Archard JA, Deng P,
Halmai J, Bauer G, Fink KD, Fury B, Perotti
NH, Walker JE, Pollock K, Apperson M,
Butters J, Belafsky P, Farwell DG, Kuhn M,
Nolta J, Anderson JD (2019) Exosomes derived
from human primed mesenchymal stem cells
induce mitosis and potentiate growth factor
secretion. Stem Cells Dev 28(6):398–409.
https://doi.org/10.1089/scd.2018.0200
12
Miriam Morente-Lo ´ pez et al.